2006
DOI: 10.1016/j.soc.2006.07.013
|View full text |Cite
|
Sign up to set email alerts
|

Evolving Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Management of Esophageal Carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2007
2007
2009
2009

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 53 publications
0
1
0
Order By: Relevance
“…An alternative to CT or MRI is PET. PET is a noninvasive test which has shown to be beneficial in detection of metastatic disease; detection of locoregional metastases is limited, however, [18]. Because of limitations of CT, MRI, and PET and advances in technology, other modalities, for example EUS, were initiated and reviewed.…”
Section: Introductionmentioning
confidence: 99%
“…An alternative to CT or MRI is PET. PET is a noninvasive test which has shown to be beneficial in detection of metastatic disease; detection of locoregional metastases is limited, however, [18]. Because of limitations of CT, MRI, and PET and advances in technology, other modalities, for example EUS, were initiated and reviewed.…”
Section: Introductionmentioning
confidence: 99%